Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.

作者: Socorro M Rodriguez-Pinilla , David Sarrio , Gema Moreno-Bueno , Yolanda Rodriguez-Gil , Miguel A Martinez

DOI: 10.1038/MODPATHOL.3800760

关键词: VimentinMolecular pathologyPhenotypeImmunohistochemistryProgesterone receptorGermlineSOX2PathologyTissue microarrayBiologyCancer research

摘要: Tumours arising in BRCA1 mutation carriers and sporadic basal-like breast carcinomas have similar phenotypic, immunohistochemical clinical characteristics. SOX2 is an embryonic transcription factor located at chromosome 3q, a region frequently gained germline mutated tumours. The aim of the study was to establish whether sox2 expression related Two hundred twenty-six node-negative invasive were immunohistochemically analysed for oestrogen receptor (ER), progesterone (PR), CK5/6, EGFR, vimentin, HER2, ki67, p53 using tissue microarrays. considered phenotype if they ER/HER2-negative CK5/6 and/or EGFR-positive. Thirty cases this series (13.7%) displayed phenotype. Sox2 observed 16.7% significantly more expressed (43.3% basal-like, 10.6% luminal 13.3% HER2+ tumours, P<0.001). Moreover, showed statistically significant inverse association with ER PR (P=0.001 0.017, respectively) direct EGFR vimentin (P=0.022, 0.005 <0.001, respectively). preferentially tumours may play role defining their less differentiated/'stem cell' phenotypic

参考文章(75)
Jose Palacios, N Benito, A Pizarro, Asuncion Suárez, Jesus Espada, A Cano, C Gamallo, Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. American Journal of Pathology. ,vol. 146, pp. 605- 612 ,(1995)
Mark R. Carter, Jason L. Hornick, Susan Lester, Christopher D.M. Fletcher, Spindle cell (sarcomatoid) carcinoma of the breast : a clinicopathologic and immunohistochemical analysis of 29 cases The American Journal of Surgical Pathology. ,vol. 30, pp. 300- 309 ,(2006) , 10.1097/01.PAS.0000184809.27735.A1
L. C. J. Dorssers, M. Timmermans, S. C. Henzen-Logmans, T. Van Agthoven, J. A. Foekens, Differential expression of estrogen, progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. American Journal of Pathology. ,vol. 144, pp. 1238- 1246 ,(1994)
Nicholas Turner, Andrew Tutt, Alan Ashworth, Hallmarks of 'BRCAness' in sporadic cancers Nature Reviews Cancer. ,vol. 4, pp. 814- 819 ,(2004) , 10.1038/NRC1457
Ryan Carlin, Duane Davis, Mark Weiss, Bruce Schultz, Deryl Troyer, Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells Reproductive Biology and Endocrinology. ,vol. 4, pp. 8- 8 ,(2006) , 10.1186/1477-7827-4-8
Anne Letessier, Fabrice Sircoulomb, Christophe Ginestier, Nathalie Cervera, Florence Monville, Véronique Gelsi-Boyer, Benjamin Esterni, Jeannine Geneix, Pascal Finetti, Christophe Zemmour, Patrice Viens, Emmanuelle Charafe-Jauffret, Jocelyne Jacquemier, Daniel Birnbaum, Max Chaffanet, Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers BMC Cancer. ,vol. 6, pp. 245- 245 ,(2006) , 10.1186/1471-2407-6-245
C Jones, A V Nonni, L Fulford, S Merrett, R Chaggar, V Eusebi, S R Lakhani, CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. British Journal of Cancer. ,vol. 85, pp. 422- 427 ,(2001) , 10.1054/BJOC.2001.1869
Mark E Robson, Pierre O Chappuis, Jaya Satagopan, Nora Wong, Jeff Boyd, John R Goffin, Clifford Hudis, David Roberge, Larry Norton, Louis R Bégin, Kenneth Offit, William D Foulkes, A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment Breast Cancer Research. ,vol. 6, pp. 1- 10 ,(2003) , 10.1186/BCR658
Sebastian Leibl, Margit Gogg-Kammerer, Andrea Sommersacher, Helmut Denk, Farid Moinfar, Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. The American Journal of Surgical Pathology. ,vol. 29, pp. 347- 353 ,(2005) , 10.1097/01.PAS.0000152133.60278.D2